RxDoctor Payments Data

Monique Taylor-Lewis

Family · Columbus, OHNPI 1669190120

Payments from drug & device makers

$886in general payments, 2019–2025

Across 49 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$153
  • AbbVie$109
  • Dexcom, Inc.$96
  • Pfizer$94
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$89
  • Phathom Pharmaceuticals, Inc.$85
  • plus $260 from 10 others

What the payments were for

  • Food & beverage$886100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$886 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$5,933
Medicare patients
32
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol53$32,601
TrulicityDulaglutide30$28,630
JardianceEmpagliflozin36$22,603
OzempicSemaglutide17$16,341
Incruse ElliptaUmeclidinium Bromide26$8,978
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen147$8,620
Breo ElliptaFluticasone/Vilanterol20$7,843
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,412
SymbicortBudesonide/Formoterol Fumarate34$7,327
Spiriva RespimatTiotropium Bromide14$7,148
LinzessLinaclotide12$6,463
Albuterol Sulfate HfaAlbuterol Sulfate274$6,436
DapagliflozinDapagliflozin Propanediol13$6,132
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$4,376
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$3,117

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$153$47,33999 claims
Boehringer IngelheimJardiance, Spiriva Respimat$15$29,75050 claims
Lilly USA, LLCTrulicity$68$28,63030 claims
AbbVieLinzess$109$6,46312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.

Other family in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →